WinNonlin: NCA of multiple dosing plasma PK profile [Software]

posted by mittyri  – Russia, 2017-01-16 18:29 (3015 d 23:04 ago) – Posting: # 16957
Views: 12,499

Dear Bob,

❝ I am primarily concerned about parameters including terminal t1/2, AUClast & inf, CL, MRT, Vss? I believe I cannot subtract baseline value from all the samples as commonly done in case of endogenously produced molecules and therefore all the listed parameters except t1/2 may not accurately represent drug profile.


Some pages from my bookmarks marked as must read each time before MD study performed/analyzed:-D:
Statistics in multiple dose study
half-life in multiple-dosed steady-state BE/BA study?

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,676 registered users;
27 visitors (0 registered, 27 guests [including 7 identified bots]).
Forum time: 18:33 CEST (Europe/Vienna)

It is true that many scientists are not philosophically minded
and have hitherto shown much skill and ingenuity
but little wisdom.    Max Born

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5